Skip to content

Vir Biotechnology

US · VIR #2824 by market cap Listed 2019
11.52 -0.08 -0.69%
Live - 5344 symbols - heartbeat 354s ago · 2026-10-08 05:34
Pre-market 11.50 -0.17%
After-hours 11.52 0.00%
Overnight 11.64 +1.04%
Market cap
1.95B
P/B
1.98
EPS
-3.16
Reader sentiment Are you bullish or bearish on VIR?

Anonymous reader poll. Unscientific, not investment advice.

Vir Biotechnology ended the session at 11.52, down 0.69%. Its market capitalisation is about 1.95B, the #2824 most valuable US-listed company we track. Wall Street's 8-analyst consensus lands on Buy, with a price target averaging 21.00 (+82% from here). Against a 52-week band of 4.82-11.94, the shares are currently 94% of the way up.

✦ StockVane Quant Insights how this is computed

Quant Rating B Buy
  • Twelve-month momentum in the top 6% of the universe, above its 200-day average.
  • Signal has read BUY for 6 months.
See the full rating history & follow-along return →
Quant Sentiment Bullish
  • Recent price momentum is +58.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 11.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

11.788.2511.522026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W +3.04%
1M +1.19%
3M +12.39%
6M +25.63%
YTD +91.04%
1Y +103.53%
3Y +30.17%
5Y -66.68%

Key statistics

Price & volume

Prev close
11.60
Open
11.32
Day range
11.32 - 11.77
Avg price
11.55
Volume
3.56M
Turnover
41.14M
Amplitude
3.84%
52-week range
4.82 - 11.94

Valuation

P/E
-3.65
P/E (TTM)
-6.51
P/B
1.98
EPS
-3.16
Net profit
-534.72M
Net assets
982.47M

Share structure

Market cap
1.95B
Float cap
1.50B
Shares out
169.22M
Float shares
129.82M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2019-10-11
52-week range 94% of range
4.82 11.94

3.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-4.32M net over the window

Short interest

Shares short
19.66M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Vir Biotechnology (VIR)?

Vir Biotechnology last traded at 11.52. The quote on this page refreshes every few seconds while US markets are open.

What is Vir Biotechnology's market cap?

About 1.95B.

What is the P/E ratio of Vir Biotechnology?

The trailing twelve-month P/E is -6.51. The Valuation tab shows it against the stock's own five-year range.

Does Vir Biotechnology pay a dividend?

Vir Biotechnology does not currently pay a regular dividend.

Is Vir Biotechnology a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 21.00, which implies 82.3% upside from the current price. This is not investment advice.

What is Vir Biotechnology's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Vir Biotechnology a B (Buy). Twelve-month momentum in the top 6% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-10-08 05:34:05 · For reference only, not investment advice and not tailored to your situation.